Immunovacc Consulting SRL
Immunovacc Consulting reported total assets of 313,729 € at the end of the 2025 financial year (annual accounts filed with the NBB on 11 Feb 2026).
The score of Immunovacc Consulting shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +31 % Total assets +24 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Immunovacc Consulting's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 16,585 € | ||||
| Equity | 273,503 € | ||||
| Cash | 205,866 € | ||||
| EBITDA | 33,184 € | ||||
| Total assets | 313,729 € |
Filed annual accounts
- Year ended 30 Jun 2025filed on 11 Feb 2026
- Year ended 30 Jun 2024filed on 17 Feb 2025
- Year ended 30 Jun 2023filed on 02 Feb 2024
- Year ended 30 Jun 2022filed on 07 Feb 2023
- Year ended 30 Jun 2021filed on 03 Feb 2022
Immunovacc Consulting's financial analysis
- Solvency87.2%sector median: 58.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Immunovacc Consulting
Immunovacc Consulting's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0830.009.006
- VAT number
- BE0830009006
- Peppol
- Registered · 0208:0830009006 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 06 Oct 2010
- Registered office
- 1435 Mont-Saint-Guibert
- Latest accounts
- 2025 · filed on 11 Feb 2026
- Activity
- Research and experimental development on other natural sciences and engineering (NACE 72109)
Immunovacc Consulting (SRL) has been based in Mont-Saint-Guibert since 2010, active in: research and experimental development on other natural sciences and engineering. For 2025, it reports a net profit of 16,585 € and equity of 273,503 €; its revenue is not published. Its solvency stands at 87.2%, above the median of its sector (58.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Immunovacc Consulting
Companies in the same business, of comparable size and area, outside its group.
- Alanine Research and experimental development on natural sciences and engineering Lasne · balance sheet 28,321 €
- IQVIA Cancer Research Research and experimental development on natural sciences and engineering Zaventem · balance sheet €1.07m
- Bimsconsult Research and experimental development on natural sciences and engineering Auderghem · balance sheet 463,296 €
- Dr. Filip Lensen Research and experimental development on natural sciences and engineering Zedelgem · balance sheet 316,295 €
- Arxios Research and experimental development on natural sciences and engineering Genappe · balance sheet 306,475 €
- AB Ecoglobe Research and experimental development on natural sciences and engineering Brussels · balance sheet 322,518 €
- HEINRICHS Amélie Research and experimental development on natural sciences and engineering Arlon · balance sheet 303,112 €
- Hello Pharma Research and experimental development on natural sciences and engineering Liège · balance sheet 302,014 €
Frequently asked questions about Immunovacc Consulting
What is the revenue of Immunovacc Consulting?
Immunovacc Consulting files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Immunovacc Consulting?
In Belgium, the VAT number is the company number prefixed with BE: BE0830009006 for Immunovacc Consulting, if the company is VAT-registered. Its company number (CBE) is 0830.009.006.
Where is the registered office of Immunovacc Consulting?
According to the CBE register, the registered office of Immunovacc Consulting is in 1435 Mont-Saint-Guibert.
What is the equity of Immunovacc Consulting?
At the close of the 2025 financial year, the equity of Immunovacc Consulting amounts to 273,503 €, a solvency of 87.2% of total assets.
Who manages Immunovacc Consulting?
The register lists 1 active mandates at Immunovacc Consulting. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Immunovacc Consulting
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →